Estonia vs Lithuania: Communicable diseases — Communicable disease incidence
Communicable diseases — Communicable disease incidence over time
- Estonia
- Lithuania
How they compare
Lithuania currently reports 21 Cases against 9 Cases in Estonia, a difference of 12 Cases.
That makes Lithuania's figure about 2.3 times Estonia's.
The two have swapped places 5 times across 20 shared years of data; in 2005 it was Estonia ahead.
Estonia ranks 7th and Lithuania ranks 5th of 7 countries.
Across the 3 decades both report, Estonia averaged higher in 1 and Lithuania in 2.
Head to head by decade
| Decade | Estonia | Lithuania | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 44 Cases | 31.2 Cases | 12.8 Cases | Estonia |
| 2010s | 27.7 Cases | 36.8 Cases | 9.1 Cases | Lithuania |
| 2020s | 13.4 Cases | 28.8 Cases | 15.4 Cases | Lithuania |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher communicable diseases — communicable disease incidence, Estonia or Lithuania?
- Lithuania, at 21 Cases against 9 Cases in Estonia as of 2024.
- What is the difference in communicable diseases — communicable disease incidence between Estonia and Lithuania?
- 12 Cases, with Lithuania ahead.
- How many years of comparable data are there for Estonia and Lithuania?
- 20 years are reported by both, from 2005 to 2024.
- How do Estonia and Lithuania rank globally for communicable diseases — communicable disease incidence?
- Estonia ranks 7th and Lithuania ranks 5th of 7 countries.
- Where does this data come from?
- Organisation for Economic Co-operation and Development, published as Communicable diseases — Communicable disease incidence. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
This dataset presents time series on Acquired Immunodeficiency Syndrome (AIDS), for the number of AIDS cases and incidence rates per 100 000 population at year of diagnosis. It also includes data on incidence of pertussis, measles, and hepatitis B, in terms of rates of reported cases per 100 000 population. Please refer to the Sources and Methods for detailed country-specific information.